General Information of DTT (ID: TTYA75N)

DTT Name MHC class II antigen DR (HLA-DR) DTT Info
Gene Name HLA-DRA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Apolizumab DMKVP7E Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
AEA-35p DMQRKXP Influenza virus infection 1E30-1E32 Phase 1 [2]
IMMU-114 DMTFUM4 Haematological malignancy 2B33.Y Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: a pilot study.
2 WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting.
3 The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD. Bone Marrow Transplant. 2012 Jul;47(7):967-80.